| Closed |
SWOG-7918 |
Phase II Evaluation of m-AMSA in Lymphoma - Hodgkin's and Non-Hodgkin's |
7/12/1979 |
4/14/1981 |
|
|
|
| Closed |
SWOG-8519 |
Phase II Evaluation of Methyl-Glyoxal Bis- Guanylhydrazone (MGBG) in Patients With Advanced Bladder Cancer |
1/1/1986 |
5/15/1989 |
|
|
Published
|
| Closed |
SWOG-7921 |
Phase II Evaluation of MGBG in Metastatic Carcinoma of the Breast |
7/12/1979 |
10/22/1980 |
|
|
|
| Closed |
S0805 |
Phase II HyperCVAD + Dasatinib with or without Allo SCT for Ph+ ALL |
9/1/2009 |
|
100% |
|
Published
|
| Closed |
S0919 |
Phase II Idarubicin/AraC + Pravastatin for Relapsed AML |
8/15/2009 |
9/15/2017 |
100% |
|
|
| Closed |
S0115 |
Phase II Melphalan + Auto PBSC Trans. for High Risk MM / Amyloidosis - BMT Study |
1/1/2004 |
10/15/2010 |
95% |
|
Published
|
| Closed |
S1108 |
Phase II MLN8237 in Peripheral T-Cell NHL |
10/28/2011 |
6/6/2013 |
100% |
|
Published
|
| Closed |
S0117 |
Phase II Mylotarg™ for Relapsed AML |
4/1/2003 |
10/15/2005 |
60% |
|
|
| Closed |
S0703 |
Phase II Older Previously Untreated Non-M3 AML |
12/1/2008 |
|
93% |
|
Published
|
| Closed |
S0636 |
Phase II OSI-774/Bevacizumab in Neversmokers with St. IIIB and IV Primary NSCLC Adenocarcinoma |
7/15/2007 |
9/1/2010 |
100% |
|
|
| Closed |
S0635 |
Phase II OSI-774/Bevacizumab in St. IIIB and IV BAC and AdenoBAC |
7/15/2007 |
8/15/2011 |
95% |
|
|
| Closed |
SWOG-8364 |
Phase II Pilot Study of Immediate Post-Operative Adjuvant Chemotherapy in Patients with Operable Breast Cancer |
5/27/1983 |
9/27/1985 |
|
|
|
| Closed |
S0432 |
Phase II Previously Untreated AML in Patients of Age 70 or Older |
9/15/2004 |
2/21/2006 |
100% |
|
Published
|
| Closed |
S0301 |
Phase II Previously Untreated Non-M3 AML in Patients of Age 56 or Older |
10/1/2003 |
12/15/2006 |
100% |
|
Published
|
| Closed |
SWOG-226 |
Phase II Protocol for Porfiromycin Solid Tumors |
7/12/1967 |
|
100% |
|
|
| Closed |
S0722 |
Phase II RAD001 in MPM |
12/1/2008 |
9/15/2011 |
100% |
|
Published
|
| Closed |
S1201 |
Phase II Rando Trt Based on ERCC1 for Advanced/Met Gastric Ca or Gastroesophageal Junction (GEJ) Ca |
2/8/2012 |
4/1/2015 |
95% |
|
|
| Open |
S1706 |
Phase II Rando, Double Blind Placebo/Veliparib + RT for Inflammatory Breast |
9/12/2018 |
|
53% |
|
|
| Closed |
S0530 |
Phase II Relapsed or Refractory ALL |
10/1/2006 |
8/1/2008 |
100% |
|
Published
|
| Closed |
S0434 |
Phase II Relapsing/Resistant Myeloma Previously Treated with Bortezomib |
3/15/2006 |
|
58% |
|
Published
|
